What You Should Know:
- Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding.
- Led by Merck Global Health Innovation Fund (MGHIF) and TechBio-focused ARTIS Ventures, the funding will help propel UNP's innovative platform and expand its reach beyond oncology, tackling a wider range of medical challenges.
Macrocycles: Nature's Key to Untapped Drug
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
KAID Health Secures $9M to Drive AI-Driven Healthcare Efficiency
What You Should Know:
- KAID Health, the AI-powered healthcare solutions pioneer, has secured a significant $9 million in funding led by Activate Venture Partners, Martinson Ventures, Boston Millennia Partners, and Brandon Hull, alongside KAID Health's Board of Directors.
- With this new funding, KAID Health plans to expand its reach to more providers and their payer partners and develop new service offerings.
Unlocking the Power of Whole Chart Analysis
KAID Health's flagship
Read More
Biorithm Secures $3.5M to Revolutionize Connected Maternity Care
What You Should Know:
- Biorithm, a global women's health medtech company, has secured $3.5M in Series A funding to fuel its mission of improving maternal health outcomes and reducing preventable pregnancy complications.
- This investment, co-led by Adaptive Capital Partners and SEEDS Capital, will support Biorithm's expansion in key markets like Southeast Asia and the United States, as well as the advancement of its flagship Femom technology.
Combating Preventable
Read More
ARTIS Ventures Closes $200M TechBio Fund to Support Next Era of Health & Medicine Innovation
What You Should Know:
- ARTIS Ventures, a pioneer in this "TechBio" revolution, announces the closing of its second fund, TechBio II, with $200M focused on healthcare and biology innovation.
- The fund aims to support early-stage companies to transform human health and well-being by leveraging growing data sets, advanced analytics, and insights.
TechBio II Investment Thesis
Diseases once deemed incurable now have hope, personalized therapies are becoming a reality, and the human body
Read More
Cytovale Secures $84M for Transformative Sepsis Diagnostic Tool
What You Should Know:
Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced it has raised $84 million in Series C funding led by Norwest Venture Partners with participation by additional new investors Sands Capital and Global Health Investment Corporation (GHIC).The financing included participation from other new and existing investors, as well as the conversion of
Read More
Intuitive Ventures Closes $150M Fund to Fuel Revolution in Minimally Invasive Care
What You Should Know:
- Intuitive Ventures, an early-stage venture capital fund dedicated to reimagining minimally invasive care, announced the close of its second fund at $150M.
- The funding signifies their unwavering commitment to supporting visionary founders who are transforming healthcare through precision diagnostics, secure digital ecosystems, and improved access to coordinated care.
Building on a Strong Foundation
In 2020, Intuitive Ventures launched its inaugural fund of
Read More
Alcohol Tracking App Sunnyside Raises $11.5M to Support Healthier Drinking Habits
What You Should Know:
- Sunnyside, an app and program that helps people build healthier habits around drinking alcohol, today announced $11.5M in Series A funding and the hire of Steve Lloyd as Chief Product and Technology Officer.
- The funding round was led by Motley Fool Ventures with major participation from Will Ventures, bringing the company's total funding to $14.6M to date. Additional Series A investors include Uncork Capital, Offline Ventures, Joyance
Read More
Pepper Bio, the ’Google Maps for Drug Discovery’, Secures $6.5M to Streamline R&D
What You Should Know:
Pepper Bio, the “Google Maps for drug discovery,” today announced an oversubscribed $6.5 million seed round led by NFX with participation from Silverton Partners, Merck Digital Sciences Studio, Mana Ventures, Tensility Ventures, VSC Ventures, and more. Pepper Bio is the world’s first transomics company, which maps data across all the -omics layers and translates it into the fastest route for discovering new drugs, finding new uses for existing
Read More
Culmination Bio Raises $10M to Bring Longitudinal Health Data to Biopharma
What You Should Know:
Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures.As a spinoff from Intermountain Health, Culmination Bio maintains exclusive rights to a physical library and cloud-based data lake covering over 40 years of de-identified patient electronic health records and biospecimen data.
Data
Read More
Vivodyne Secures $38M for AI-Powered Drug Discovery Platform
What You Should Know:
- Vivodyne, a biotech company that accelerates drug discovery by testing therapies on lab-grown human organs raises $38M in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS Ventures, MBX Capital, and Bison Ventures.
- The funding will support Vivodyne's development of a clinically predictive AI stack and discovery pipeline, which utilizes lab-grown human organ tissues to identify novel therapeutic targets and predict patient
Read More
